Epigenomics AG appoints Albert Weber as Executive Vice President Finance

01-Dec-2017 - Germany

Epigenomics AG announced that the Supervisory Board appointed Albert Weber Executive Vice President of Finance effective January 1, 2018.  Mr. Weber, who has worked at Epigenomics for the past seventeen years, will become a member of the Executive Board of Epigenomics and continue to oversee the company’s financial, accounting and controlling departments.

Mr. Weber (54), has more than 25 years of corporate finance experience including the last seventeen years at Epigenomics. Prior to this recent appointment Mr. Weber was the Senior Vice President of Finance, Accounting and Controlling for Epigenomics.  Prior to joining the company, Albert served as Manager Controlling of Pironet AG, a Cologne based IT start-up and previously at EMI Group Germany as the Manager Treasury and Corporate Accounting.  Mr. Weber has experience in capital raises, all corporate finance functions and IPO’s. He has a degree in Business Administration from Cologne University and is certified in IFRS accounting.

Heino von Prondzynski, Chairman of the Supervisory Board, stated: “The Supervisory Board is very happy to recognize Albert’s hard work and dedication to Epigenomics by adding him the Executive Board.  Mr. Weber’s financial experience will be a valued benefit to the Executive Board as the company prepares for the next stage of growth.”

“I am excited to join the Executive Board,” said Mr. Weber. “I’ve been with Epigenomics for seventeen years and I’m truly excited about the amazing opportunity in front of the company. I look forward to helping the organization transform the colorectal screening market.”

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?